Global Therapeutic Vaccines Market to Witness a Moderate CAGR During 2021-2029; Increasing Prevalence of Chronic & Infectious Diseases to Create Opportunities for Market Growth

Research Nester published a report titled “Therapeutic Vaccines Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global therapeutic vaccines market in terms of market segmentation by type of vaccines, technology, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global therapeutic vaccines market is segmented by type of vaccines into addiction, infectious disease, autoimmune disease, and neurological disease vaccines, out of which, the autoimmune disease segment is projected to hold the largest market share by the end of 2021, owing to the high prevalence of the autoimmune diseases amongst individuals, along with the increasing awareness for such diseases and the rising research and development for the development of autoimmune disease drugs.

The global therapeutic vaccines market is anticipated to witness a moderate CAGR during the forecast period, i.e., 2021-2029, on account of the increasing prevalence of chronic and infectious diseases around the globe, coupled with the favorable support of the government by means of funding initiatives to promote advanced research in the field of therapeutic vaccines. The World Health Organization (WHO), in one of its statistics, stated that in the year 2016, around 17.9 million people died from cardiovascular diseases (CVDs).

Regionally, the global therapeutic vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the market in North America is projected to hold the largest market share by the end of 2029 owing to the growing expenditure of the government of the United States for advancements in medical research, coupled with the availability of a strong healthcare network.

Growing Prevalence of Diseases to Drive Market Growth

Poor food habits and lifestyle are some of the major causes that are raising the prevalence of diseases. On the other hand, the increasing concern for the spread of several infectious and viral diseases, including diseases such as coronavirus, is raising the need for the development of vaccines that can help cure patients. Additionally, increasing research and development, backed by the funding of governments as well as healthcare organizations, are some of the additional factors anticipated to drive the market growth.

However, the stringent regulatory framework of the government which significantly raises the cost of the project of the vaccine manufacturers owing to the multiple clinical trials that needs to be made are expected to operate as key restraint to the growth of the global therapeutic vaccines market over the forecast period.

Download Sample of This Strategic Report

This report also provides the existing competitive scenario of some of the key players of the global therapeutic vaccines market which includes company profiling of SCM Lifescience (KOSDAQ: 298060), Agenus Inc. (NASDAQ: AGEN), Kuros Biosciences (OTCMKTS: CSBTF), CureVac AG (NASDAQ: CVAC), CEL-SCI (NYSEAMERICAN: CVM), Ipsen Pharma (OTCMKTS: IPSEY), Cell Culture Company, LLC, AFFiRiS AG, Celldex Therapeutics (NASDAQ: CLDX), and Bavarian Nordic (OTCMKTS: BVNRY). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global therapeutic vaccines market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.